AA
PACB icon

AQR Arbitrage’s Pacific Biosciences PACB Stock Holding History

AQR Arbitrage’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,953,621
Closed -$35.7M – 584
2019
Q4 		$35.7M Buy
6,953,621
+85,650
+1% +$435K 0.6% 40
2019
Q3 		$35.4M Sell
6,867,971
-47,240
-0.7% -$264K 0.52% 39
2019
Q2 		$41.8M Buy
6,915,211
+164,084
+2% +$1.15M 0.48% 53
2019
Q1 		$48.8M Buy
6,751,127
+166,229
+3% +$1.2M 0.61% 40
2018
Q4 		$48.7M Buy
+6,584,898
New +$41.7M 0.67% 40

Other funds holding PACB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
KLCMU
Kite Lake Capital Management (UK) London, United Kingdom $99.1M AUM 198.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WIC
Water Island Capital New York $750M AUM 107.59% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $3.94B AUM 30.77% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return